+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Epinephrine Auto-Injector Market Research Report by Dosage, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 229 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5437805
UP TO OFF until Dec 31st 2022
The Global Epinephrine Auto-Injector Market size was estimated at USD 292.68 million in 2021, USD 320.33 million in 2022, and is projected to grow at a CAGR 9.62% to reach USD 508.04 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Epinephrine Auto-Injector to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Dosage, the market was studied across 0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, and Mg Epinephrine Autoinjector.
  • Based on End-User, the market was studied across Clinics, Hospital, and Individual.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Epinephrine Auto-Injector market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Epinephrine Auto-Injector Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Epinephrine Auto-Injector Market, including ALK-Abello A/S, Amedra Pharmaceuticals LLC, Amgen Inc., Amneal Pharmaceuticals Inc., Antares Pharma Inc., Bausch Health Companies, Inc., Bayer AG, Becton, Dickinson and Company, BPI Labs, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Hospice Inc, Hospira Inc., Impax Laboratories, Inc., Janssen Global Services, LLC, Kaleo, Inc., Lincoln Medical Centre Ltd., Lincoln Medical Ltd, Merck KGaA, Mylan Inc, Novartis International AG, Pfizer, Inc., Sanofi SA, Teva Pharmaceuticals Lts, and Ypsomed Holding.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Epinephrine Auto-Injector Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Epinephrine Auto-Injector Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Epinephrine Auto-Injector Market?
4. What is the competitive strategic window for opportunities in the Global Epinephrine Auto-Injector Market?
5. What are the technology trends and regulatory frameworks in the Global Epinephrine Auto-Injector Market?
6. What is the market share of the leading vendors in the Global Epinephrine Auto-Injector Market?
7. What modes and strategic moves are considered suitable for entering the Global Epinephrine Auto-Injector Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness about allergies
5.1.1.2. Technological developments in research & development activities
5.1.1.3. High demand for autoinjectors instead of conventional devices such as standard syringes
5.1.2. Restraints
5.1.2.1. High cost of epinephrine auto injector
5.1.3. Opportunities
5.1.3.1. Demand for easy usability of disposable drug injectors
5.1.3.2. Increase in the demand for self-management of anaphylaxis
5.1.4. Challenges
5.1.4.1. Stringent regulations imposed by the government
5.2. Cumulative Impact of COVID-19
6. Epinephrine Auto-Injector Market, by Dosage
6.1. Introduction
6.2. 0.3 Mg Epinephrine Autoinjector
6.3. 0.5 Mg Epinephrine Autoinjector
6.4. Mg Epinephrine Autoinjector
7. Epinephrine Auto-Injector Market, by End-User
7.1. Introduction
7.2. Clinics
7.3. Hospital
7.4. Individual
8. Americas Epinephrine Auto-Injector Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Epinephrine Auto-Injector Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Epinephrine Auto-Injector Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. ALK-Abello A/S
12.2. Amedra Pharmaceuticals LLC
12.3. Amgen Inc.
12.4. Amneal Pharmaceuticals Inc.
12.5. Antares Pharma Inc.
12.6. Bausch Health Companies, Inc.
12.7. Bayer AG
12.8. Becton, Dickinson and Company
12.9. BPI Labs, Inc.
12.10. Eli Lilly and Company
12.11. GlaxoSmithKline PLC
12.12. Hospice Inc
12.13. Hospira Inc.
12.14. Impax Laboratories, Inc.
12.15. Janssen Global Services, LLC
12.16. Kaleo, Inc.
12.17. Lincoln Medical Centre Ltd.
12.18. Lincoln Medical Ltd
12.19. Merck KGaA
12.20. Mylan Inc
12.21. Novartis International AG
12.22. Pfizer, Inc.
12.23. Sanofi SA
12.24. Teva Pharmaceuticals Lts
12.25. Ypsomed Holding
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET DYNAMICS
FIGURE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2027
FIGURE 11. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 18. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2027
FIGURE 20. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 28. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2027
FIGURE 30. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 36. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2027
FIGURE 38. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 40. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2027
FIGURE 42. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2027
FIGURE 57. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 69. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 41. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 43. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 44. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 46. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 47. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 49. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 50. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 52. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 56. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 57. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 61. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 63. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 64. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 66. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 67. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 69. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 70. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 72. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 73. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 75. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 76. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 78. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 79. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 81. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 82. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 84. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 85. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 87. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 88. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 90. TAIWAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 91. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 93. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 98. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 100. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 101. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 103. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 104. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 106. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 107. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 109. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 110. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 112. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 113. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 115. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 116. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 118. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 119. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 121. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 122. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 124. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 128. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2019-2027 (USD MILLION)
TABLE 130. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 131. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 132. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 133. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 134. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET RANKING
TABLE 135. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SHARE, BY KEY PLAYER, 2021
TABLE 136. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET MERGER & ACQUISITION
TABLE 137. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 138. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 139. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET INVESTMENT & FUNDING
TABLE 140. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 141. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: LICENSE & PRICING

Companies Mentioned

  • ALK-Abello A/S
  • Amedra Pharmaceuticals LLC
  • Amgen Inc.
  • Amneal Pharmaceuticals Inc.
  • Antares Pharma Inc.
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • BPI Labs, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Hospice Inc
  • Hospira Inc.
  • Impax Laboratories, Inc.
  • Janssen Global Services, LLC
  • Kaleo, Inc.
  • Lincoln Medical Centre Ltd.
  • Lincoln Medical Ltd
  • Merck KGaA
  • Mylan Inc
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi SA
  • Teva Pharmaceuticals Lts
  • Ypsomed Holding

Methodology

Loading
LOADING...